Serum Triglycerides and Clinical Benefit in Lipid-Lowering Trials

Trial evidence shows that effective lowering of serum total cholesterol and particularly of low-density lipoprotein (LDL) cholesterol is important for the prevention of total mortality, coronary artery disease mortality, and major coronary events. The role of serum triglyceride reduction in achievin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 1998-02, Vol.81 (4), p.70B-73B
1. Verfasser:	Kesaniemi, Y Antero
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticholesteremic Agents - administration & dosage Bezafibrate - administration & dosage Biological and medical sciences Cardiology Cholesterol Cholesterol, LDL - blood Clinical trials Clinical Trials as Topic Coronary Artery Disease - drug therapy Coronary Disease - prevention & control Estrogen Replacement Therapy Female General and cellular metabolism. Vitamins Humans Hypertriglyceridemia - blood Hypertriglyceridemia - drug therapy Hypolipidemic Agents - administration & dosage Lipids Medical sciences Myocardial Infarction - drug therapy Myocardial Ischemia - drug therapy Pharmacology. Drug treatments Postmenopause Pravastatin - administration & dosage Risk Factors Simvastatin - administration & dosage Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!